透析市场规模、份额、成长分析，按类型、按产品/服务、按最终用户、按地区 - 行业预测，2024-2031

2022年全球透析市场规模将为1108亿美元，从2023年的1158.2亿美元增长到2031年的1624.5亿美元，在预测期内（2024-2031年）预计复合年增长率为4.32%。

由于慢性肾臟病病率显着增加，导致肾臟诊所寻求治疗的患者数量增加，透析市场正在强劲增长。这一趋势得到了私人和政府机构收紧支付政策的支持，特别是美国医疗保险和医疗补助服务中心 (CMS)。例如，2019 年，CMS 向约 7,000 名末期肾病 (ESRD) 提供者分配了约 103 亿美元的医疗保险报销，以支付血液透析机费用。预计此类财务支持将在未来几年刺激市场扩张。据美国国立卫生研究院（NIH）称，约5%的新冠患者需要肾臟替代治疗，许多重症患者患有急性肾损伤。为了满足这些迫切需求，医院越来越多地引进肾臟治疗设备，进一步推动了市场的成长轨迹。因此，美国市场情势预计将呈现持续成长，并有望在预测期内实现稳定的复合年增长率。这反映了肾臟相关疾病紧迫的医疗需求和不断变化的治疗前景。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 专利分析
• 技术分析
• 监管环境

透析市场：按类型

• 市场概况
• 血液透析机
  • 传统血液透析机
  • 短期透析
  • 夜间血液透析机
• 腹膜透析
  • 连续性携带式腹膜透析 (CAPD) 透析
  • 自动腹膜透析（APD）

透析市场：依产品/服务分类

• 市场概况
• 服务
• 装置
  • 透析设备
  • 水疗系统
  • 其他的
• 消耗品
  • 透析设备
  • 导管
  • 其他的
• 透析药物

透析市场：依最终用户分类

• 市场概况
• 中心透析
• 家庭透析治疗

透析市场规模：按地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Asahi Kasei Corporation
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton Dickinson and Company
• DaVita Inc.
• Fresenius Medical Care AG & Co. KGaA
• JMS Co. Ltd.
• Medtronic plc
• Nikkiso Co. Ltd.
• NIPRO Corporation
• Satellite Healthcare Inc.
• Toray Industries Inc.
• Diaverum Deutschland GmbH
• NxStage Medical, Inc.
• Rockwell Medical Technologies, Inc.
• AllMed Medical GmbH
• Fresenius Kabi AG
• Quanta Dialysis Technologies Ltd.
• Outset Medical, Inc.
• Medica SpA

Global Dialysis Market size was valued at USD 110.80 billion in 2022 and is poised to grow from USD 115.82 billion in 2023 to USD 162.45 billion by 2031, growing at a CAGR of 4.32% during the forecast period (2024-2031).

The dialysis market is experiencing robust growth due to a significant rise in chronic kidney disease prevalence, leading to more patients seeking treatment at renal clinics. Enhanced payment policies from commercial and government entities, particularly the Centers for Medicare & Medicaid Services (CMS), support this trend; for instance, in 2019, CMS allocated roughly US$ 10.3 billion in Medicare reimbursements to around 7,000 end-stage renal disease (ESRD) providers to cover hemodialysis costs. This financial backing is expected to fuel market expansion in the coming years. Additionally, the recent COVID-19 pandemic has exacerbated the demand for renal equipment, as many critically ill patients suffer from acute kidney injury, with about 5% of COVID cases requiring renal replacement therapy according to the National Institutes of Health (NIH). Hospitals are increasingly adopting renal therapy equipment to meet this urgent need, further driving the market's growth trajectory. As a result, the US dialysis market is positioned for sustained growth, projected to achieve a consistent compound annual growth rate (CAGR) in the upcoming forecast period, reflecting both the pressing healthcare demands and the evolving treatment landscape for kidney-related disorders.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dialysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dialysis Market Segmental Analysis

Global Dialysis Market is segmented by Type, Products and Services, End User, and Region. Based on Type, the market is segmented into Hemodialysis (Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis), Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)). Based on Products and Services, the market is segmented into Services, Equipment (Dialysis Machines, Water Treatment Systems, Others), Consumables (Dialyzers, Catheters, Others), Dialysis Drugs. Based on End User, the market is segmented into In-center Dialysis, Home Dialysis. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Dialysis Market

The escalating prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) is a significant market driver for the global dialysis market. As the burden of ESRD increases, necessitating long-term renal therapies or transplants, healthcare systems face immense financial pressures, thereby escalating the demand for efficient dialysis services. With approximately 15% of the U.S. population affected by CKD, the urgency for accessible renal care is heightened. Additionally, the expansion of nephrology specialists and renal care facilities in developed nations, coupled with investments aimed at establishing dialysis centers in emerging markets like India and China, underscores a robust growth trajectory. This demand for affordable yet effective renal treatments is projected to fuel substantial market revenue generation, making it a pivotal factor in the global dialysis landscape.

Restraints in the Global Dialysis Market

The global dialysis market faces significant restraint due to the growing preference for kidney transplantation as a treatment for end-stage renal disease (ESRD) and stage III chronic kidney disease (CKD). Patients often opt for transplantation over dialysis, attracted by the potential for better long-term outcomes and improved quality of life. Favorable reimbursement policies make kidney transplantation a more financially viable option, further driving this shift. Additionally, the rising costs associated with renal therapy, exacerbated by the coronavirus pandemic-especially in countries like India-may deter patients from opting for dialysis, ultimately hindering market growth and adoption of dialysis treatments.

Market Trends of the Global Dialysis Market

The Global Dialysis market is witnessing a significant trend of transitioning from traditional clinic-based care to homecare settings, driven by patient preferences, especially in developed economies. This shift is complemented by government initiatives, particularly in the United States, aimed at promoting cost-effective home treatment options for end-stage renal disease (ESRD). The emergence of advanced renal care technologies, including innovative dialysis machines and efficient dialyzers, is further propelling market growth, with key players like B.Braun and Fresenius Kabi leading the charge in product development. The focus on enhancing accessibility to homecare is expected to attract a growing number of patients seeking convenient and personalized treatment options, heralding a transformative phase in the dialysis landscape.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Types
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Patent Analysis
• Technology Analysis
• Regulatory Landscape

Dialysis Market, By Type

• Market Overview
• Hemodialysis
  • Conventional Hemodialysis
  • Short Daily Hemodialysis
  • Nocturnal Hemodialysis
• Peritoneal Dialysis
  • Continuous Ambulatory Peritoneal Dialysis (CAPD)
  • Automated Peritoneal Dialysis (APD)

Dialysis Market, By Products and Services

• Market Overview
• Services
• Equipment
  • Dialysis Machines
  • Water Treatment Systems
  • Others
• Consumables
  • Dialyzers
  • Catheters
  • Others
• Dialysis Drugs

Dialysis Market, By End User

• Market Overview
• In-center Dialysis
• Home Dialysis

Dialysis Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Asahi Kasei Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DaVita Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care AG & Co. KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JMS Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikkiso Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NIPRO Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Satellite Healthcare Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Toray Industries Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diaverum Deutschland GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NxStage Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rockwell Medical Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AllMed Medical GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quanta Dialysis Technologies Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Outset Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medica S.p.A
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments